home / stock / nrix / nrix message board
Subject | By | Source | When |
---|---|---|---|
https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/8889 | TheFinalCD | investorshub | 08/23/2022 11:04:42 PM |
what the F is wrong with this fkn | infamous | investorshub | 03/24/2021 7:21:29 PM |
$CEO: Dr. Arthur T. Sands | Phosphene | investorshub | 12/09/2020 11:20:59 PM |
Strategic partnerships with Sanofi and Gilead Sciences Inc. | Phosphene | investorshub | 12/08/2020 5:01:07 AM |
Data support a planned clinical trial of NX-2127 | Phosphene | investorshub | 12/08/2020 4:50:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Nurix Therapeutics Inc. Company Name:
NRIX Stock Symbol:
NASDAQ Market:
Nurix Therapeutics Inc. Website:
2024-07-12 17:15:01 ET Oppenheimer analyst issues OUTPERFORM recommendation for NRIX on July 12, 2024 03:19PM ET. The previous analyst recommendation was Outperform. NRIX was trading at $23.82 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Presented positive clinical data at the European Hematology Association Congress supporting a potential best-in-class profile for NX-5948 for the treatment of CLL Strengthened leadership with appointment of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa,...
SAN FRANCISCO, July 08, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced that Arthur T. Sands, M.D., Ph.D., pr...